Chloroquine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1063753
  • May 2021
  • Pharmaceuticals
  • 117 Pages
The Chloroquine market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Chloroquine market research report recommends a business strategy for present market participants to strengthen their position in the market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered ABCAM PLC, ADVANZ PHARMA CORP., BAYER AG, CADILA HEALTHCARE LTD., IPCA LABORATORIES LTD., MYLAN NV, NOVARTIS AG, SANOFI, SUN PHARMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICAL INDUSTRIES LTD., ALLIANCE PHARMACEUTICALS, MERCK, UNIPRIX, RISING PHARMACEUTICALS, FISHMAN CHEMICAL
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Chloroquine market along with their effects over the forecast period. Similarly, according to the region Chloroquine market research report includes the study of opportunities available in the market situation.

The Chloroquine market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.

Major Key Players for Global Chloroquine Market:
The Chloroquine market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. ABCAM PLC, ADVANZ PHARMA CORP., BAYER AG, CADILA HEALTHCARE LTD., IPCA LABORATORIES LTD., MYLAN NV, NOVARTIS AG, SANOFI, SUN PHARMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICAL INDUSTRIES LTD., ALLIANCE PHARMACEUTICALS, MERCK, UNIPRIX, RISING PHARMACEUTICALS, FISHMAN CHEMICAL

Chloroquine Market Segmentation Analysis:
By Product
Injectables
Capsules
Tablets
Application
Malaria
Rheumatoid Arthritis
Others

Global Chloroquine Market Segmentation by Regions:
In regional analysis, Chloroquine market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Chloroquine market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Chloroquine Market: Value and Forecast
  • U.S.
  • Canada
 Europe Region for Chloroquine Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 Asia Pacific Region for Chloroquine Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 Latin America Region for Chloroquine Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 Middle East and Africa for Chloroquine Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Important Points Covered by Report:
  • To analyze the value of the Chloroquine market, according to the key region.
  • To study the Chloroquine market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Chloroquine market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Chloroquine research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Chloroquine market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Chloroquine market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Chloroquine market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Chloroquine market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Chloroquine market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • ABCAM PLC
  • ADVANZ PHARMA CORP.
  • BAYER AG
  • CADILA HEALTHCARE LTD.
  • IPCA LABORATORIES LTD.
  • MYLAN NV
  • NOVARTIS AG
  • SANOFI
  • SUN PHARMACEUTICAL INDUSTRIES LTD.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • ALLIANCE PHARMACEUTICALS
  • MERCK
  • UNIPRIX
  • RISING PHARMACEUTICALS
  • FISHMAN CHEMICAL
  • Injectables
  • Capsules
  • Tablets
  • Malaria
  • Rheumatoid Arthritis
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Chloroquine Market Snapshot
          2.1.1. Global Chloroquine Market By Product,2019
               2.1.1.1.Injectables
               2.1.1.2.Capsules
               2.1.1.3.Tablets
          2.1.2. Global Chloroquine Market By Application,2019
               2.1.2.1.Malaria
               2.1.2.2.Rheumatoid Arthritis
               2.1.2.3.Others
          2.1.3. Global Chloroquine Market By End-use,2019
          2.1.4. Global Chloroquine Market By Geography,2019

3. Global Chloroquine Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Chloroquine Market Size (US$), By Product, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Product, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Product, 2020
     4.2. Global Chloroquine Market Size (US$), By Product, 2018 – 2028

5. Global Chloroquine Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Chloroquine Market Size (US$), By Application, 2018 – 2028

6. Global Chloroquine Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Chloroquine Market Size (US$), By End-use, 2018 – 2028

7. Global Chloroquine Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Chloroquine Market Analysis, 2018 – 2028 
          7.2.1. North America Chloroquine Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Chloroquine Market Size (US$), By Product, 2018 – 2028
          7.2.3. North America Chloroquine Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Chloroquine Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Chloroquine Market Analysis, 2018 – 2028 
          7.3.1.  Europe Chloroquine Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Chloroquine Market Size (US$), By Product, 2018 – 2028
          7.3.3. Europe Chloroquine Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Chloroquine Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Chloroquine Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Chloroquine Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Chloroquine Market Size (US$), By Product, 2018 – 2028
          7.4.3. Asia Pacific Chloroquine Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Chloroquine Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Chloroquine Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Chloroquine Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Chloroquine Market Size (US$), By Product, 2018 – 2028
          7.5.3. Latin America Chloroquine Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Chloroquine Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Chloroquine Market Analysis, 2018 – 2028 
          7.6.1.  MEA Chloroquine Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Chloroquine Market Size (US$), By Product, 2018 – 2028
          7.6.3. MEA Chloroquine Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Chloroquine Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Chloroquine Providers
        8.4.1 ABCAM PLC
                8.4.1.1 Business Description
                8.4.1.2 ABCAM PLC Geographic Operations
                8.4.1.3 ABCAM PLC Financial Information
                8.4.1.4 ABCAM PLC Product Positions/Portfolio
                8.4.1.5 ABCAM PLC Key Developments
        8.4.2 ADVANZ PHARMA CORP.
                8.4.2.1 Business Description
                8.4.2.2 ADVANZ PHARMA CORP. Geographic Operations
                8.4.2.3 ADVANZ PHARMA CORP. Financial Information
                8.4.2.4 ADVANZ PHARMA CORP. Product Positions/Portfolio
                8.4.2.5 ADVANZ PHARMA CORP. Key Developments
        8.4.3 BAYER AG
                8.4.3.1 Business Description
                8.4.3.2 BAYER AG Geographic Operations
                8.4.3.3 BAYER AG Financial Information
                8.4.3.4 BAYER AG Product Positions/Portfolio
                8.4.3.5 BAYER AG Key Developments
        8.4.4 CADILA HEALTHCARE LTD.
                8.4.4.1 Business Description
                8.4.4.2 CADILA HEALTHCARE LTD. Geographic Operations
                8.4.4.3 CADILA HEALTHCARE LTD. Financial Information
                8.4.4.4 CADILA HEALTHCARE LTD. Product Positions/Portfolio
                8.4.4.5 CADILA HEALTHCARE LTD. Key Developments
        8.4.5 IPCA LABORATORIES LTD.
                8.4.5.1 Business Description
                8.4.5.2 IPCA LABORATORIES LTD. Geographic Operations
                8.4.5.3 IPCA LABORATORIES LTD. Financial Information
                8.4.5.4 IPCA LABORATORIES LTD. Product Positions/Portfolio
                8.4.5.5 IPCA LABORATORIES LTD. Key Developments
        8.4.6 MYLAN NV
                8.4.6.1 Business Description
                8.4.6.2 MYLAN NV Geographic Operations
                8.4.6.3 MYLAN NV Financial Information
                8.4.6.4 MYLAN NV Product Positions/Portfolio
                8.4.6.5 MYLAN NV Key Developments
        8.4.7 NOVARTIS AG
                8.4.7.1 Business Description
                8.4.7.2 NOVARTIS AG Geographic Operations
                8.4.7.3 NOVARTIS AG Financial Information
                8.4.7.4 NOVARTIS AG Product Positions/Portfolio
                8.4.7.5 NOVARTIS AG Key Developments
        8.4.8 SANOFI
                8.4.8.1 Business Description
                8.4.8.2 SANOFI Geographic Operations
                8.4.8.3 SANOFI Financial Information
                8.4.8.4 SANOFI Product Positions/Portfolio
                8.4.8.5 SANOFI Key Developments
        8.4.9 SUN PHARMACEUTICAL INDUSTRIES LTD.
                8.4.9.1 Business Description
                8.4.9.2 SUN PHARMACEUTICAL INDUSTRIES LTD. Geographic Operations
                8.4.9.3 SUN PHARMACEUTICAL INDUSTRIES LTD. Financial Information
                8.4.9.4 SUN PHARMACEUTICAL INDUSTRIES LTD. Product Positions/Portfolio
                8.4.9.5 SUN PHARMACEUTICAL INDUSTRIES LTD. Key Developments
        8.4.10 TEVA PHARMACEUTICAL INDUSTRIES LTD.
                8.4.10.1 Business Description
                8.4.10.2 TEVA PHARMACEUTICAL INDUSTRIES LTD. Geographic Operations
                8.4.10.3 TEVA PHARMACEUTICAL INDUSTRIES LTD. Financial Information
                8.4.10.4 TEVA PHARMACEUTICAL INDUSTRIES LTD. Product Positions/Portfolio
                8.4.10.5 TEVA PHARMACEUTICAL INDUSTRIES LTD. Key Developments
        8.4.11 ALLIANCE PHARMACEUTICALS
                8.4.11.1 Business Description
                8.4.11.2 ALLIANCE PHARMACEUTICALS Geographic Operations
                8.4.11.3 ALLIANCE PHARMACEUTICALS Financial Information
                8.4.11.4 ALLIANCE PHARMACEUTICALS Product Positions/Portfolio
                8.4.11.5 ALLIANCE PHARMACEUTICALS Key Developments
        8.4.12 MERCK
                8.4.12.1 Business Description
                8.4.12.2 MERCK Geographic Operations
                8.4.12.3 MERCK Financial Information
                8.4.12.4 MERCK Product Positions/Portfolio
                8.4.12.5 MERCK Key Developments
        8.4.13 UNIPRIX
                8.4.13.1 Business Description
                8.4.13.2 UNIPRIX Geographic Operations
                8.4.13.3 UNIPRIX Financial Information
                8.4.13.4 UNIPRIX Product Positions/Portfolio
                8.4.13.5 UNIPRIX Key Developments
        8.4.14 RISING PHARMACEUTICALS
                8.4.14.1 Business Description
                8.4.14.2 RISING PHARMACEUTICALS Geographic Operations
                8.4.14.3 RISING PHARMACEUTICALS Financial Information
                8.4.14.4 RISING PHARMACEUTICALS Product Positions/Portfolio
                8.4.14.5 RISING PHARMACEUTICALS Key Developments
        8.4.15 FISHMAN CHEMICAL
                8.4.15.1 Business Description
                8.4.15.2 FISHMAN CHEMICAL Geographic Operations
                8.4.15.3 FISHMAN CHEMICAL Financial Information
                8.4.15.4 FISHMAN CHEMICAL Product Positions/Portfolio
                8.4.15.5 FISHMAN CHEMICAL Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Chloroquine Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Chloroquine Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Chloroquine Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Chloroquine Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Chloroquine Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Chloroquine Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Chloroquine Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Chloroquine Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Chloroquine Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Chloroquine Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Chloroquine Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Chloroquine Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Chloroquine Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Chloroquine Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Chloroquine Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Chloroquine Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Chloroquine: Market Segmentation 
FIG. 2 Global Chloroquine Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Chloroquine Market, By Product, 2019 (US$ Mn) 
FIG. 5 Global Chloroquine Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Chloroquine Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Chloroquine Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Chloroquine Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Chloroquine Providers, 2019
FIG. 11 Global Chloroquine Market Revenue Contribution, By Product, 2019 & 2028 (Value %) 
FIG. 12 Global Chloroquine Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Chloroquine Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Chloroquine Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Chloroquine Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Chloroquine Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Chloroquine Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Chloroquine Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Chloroquine market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Chloroquine Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Chloroquine Market Value, By Segment1, 2018 – 2028
TABLE  North America Chloroquine Market Value, By Segment2, 2018 – 2028
TABLE  North America Chloroquine Market Value, By Country, 2018 – 2028
TABLE  Europe Chloroquine Market Value, By Segment1, 2018 – 2028
TABLE  Europe Chloroquine Market Value, By Segment2, 2018 – 2028
TABLE  Europe Chloroquine Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Chloroquine Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Chloroquine Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Chloroquine Market Value, By Country, 2018 – 2028
TABLE  Latin America Chloroquine Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Chloroquine Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Chloroquine Market Value, By Country, 2018 – 2028
TABLE  MEA Chloroquine Market Value, By Segment1, 2018 – 2028
TABLE  MEA Chloroquine Market Value, By Segment2, 2018 – 2028
TABLE  MEA Chloroquine Market Value, By Country, 2018 – 2028
TABLE  ABCAM PLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ADVANZ PHARMA CORP.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  BAYER AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  CADILA HEALTHCARE LTD.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  IPCA LABORATORIES LTD.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  MYLAN NV: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  NOVARTIS AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  SANOFI: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  SUN PHARMACEUTICAL INDUSTRIES LTD.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  TEVA PHARMACEUTICAL INDUSTRIES LTD.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ALLIANCE PHARMACEUTICALS: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  MERCK: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  UNIPRIX: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  RISING PHARMACEUTICALS: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  FISHMAN CHEMICAL: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Chloroquine Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Chloroquine Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Chloroquine Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Chloroquine Market, By Geography, 2019 (US$ Mn)
FIG.  Global Chloroquine Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Chloroquine Providers, 2016
FIG.  Global Chloroquine Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Capsules Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Tablets Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Chloroquine Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Rheumatoid Arthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Chloroquine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Chloroquine Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Chloroquine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Chloroquine Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Chloroquine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Chloroquine Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Chloroquine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Chloroquine Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Chloroquine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Chloroquine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Chloroquine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Chloroquine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Chloroquine Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Chloroquine Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Chloroquine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Chloroquine Market Value, 2018 – 2028, (US$ Mn)